Intercept Pharmaceuticals (NASDAQ:ICPT) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on ICPT. Canaccord Genuity Group reiterated a hold rating and issued a $19.00 price objective (down from […]
More Stories
Needham & Company LLC Lowers Bitdeer Technologies Group (NASDAQ:BTDR) Price Target to $15.00
Bitdeer Technologies Group (NASDAQ:BTDR – Get Free Report) had its price objective dropped by Needham & Company LLC from $18.00...
iShares High Yield Active ETF (NASDAQ:BRHY) Sees Large Increase in Short Interest
iShares High Yield Active ETF (NASDAQ:BRHY – Get Free Report) saw a large growth in short interest in February. As...
Zacks Research Predicts Weaker Earnings for Allegiant Travel
Allegiant Travel (NASDAQ:ALGT – Free Report) – Investment analysts at Zacks Research cut their Q1 2026 earnings per share (EPS)...
FY2025 Earnings Estimate for ADENTRA Issued By Cormark
ADENTRA Inc. (TSE:ADE – Free Report) – Research analysts at Cormark issued their FY2025 earnings estimates for ADENTRA in a...
Clarus Securities Lifts Earnings Estimates for K92 Mining
K92 Mining Inc. (TSE:KNT – Free Report) – Equities research analysts at Clarus Securities boosted their FY2025 EPS estimates for...
Noble Financial Has Negative Outlook of TSQ FY2026 Earnings
Townsquare Media, Inc. (NYSE:TSQ – Free Report) – Investment analysts at Noble Financial cut their FY2026 earnings estimates for Townsquare...